{"id":43911,"date":"2015-09-17T11:25:58","date_gmt":"2015-09-17T16:25:58","guid":{"rendered":"https:\/\/content.findlaw-admin.com\/ability-legal\/contracts\/uncategorized\/schedule-13g-ampex-corp.html"},"modified":"2015-09-17T11:25:58","modified_gmt":"2015-09-17T16:25:58","slug":"schedule-13g-ampex-corp","status":"publish","type":"corporate_contracts","link":"https:\/\/corporate.findlaw.com\/contracts\/securities\/schedule-13g-ampex-corp.html","title":{"rendered":"Schedule 13G &#8211; Ampex Corp."},"content":{"rendered":"<p>UNITED STATES<\/p>\n<p>SECURITIES AND EXCHANGE COMMISSION<\/p>\n<p>Washington, D.C. 20549<\/p>\n<\/p>\n<p>SCHEDULE 13G<\/p>\n<\/p>\n<p>Under the Securities Exchange Act of 1934<\/p>\n<\/p>\n<\/p>\n<p>AMPEX CORPORATION<\/p>\n<p>\n&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;\n<\/p>\n<p>(Name of Issuer)<\/p>\n<\/p>\n<p>Class A Common Stock, par value $0.01 per share<\/p>\n<p>\n&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;\n<\/p>\n<p>(Title of Class of Securities)<\/p>\n<\/p>\n<p>032092-30-6<\/p>\n<p>\n&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;\n<\/p>\n<p>(CUSIP Number)<\/p>\n<\/p>\n<p>April 1, 2008<\/p>\n<p>\n&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;\n<\/p>\n<p>(Date of Event Which Requires Filing of this Statement)<\/p>\n<\/p>\n<p>Check the appropriate box to designate the rule pursuant to which this<br \/>\nSchedule<\/p>\n<p>13G is filed:<\/p>\n<p>[ ] Rule 13d-1(b)<\/p>\n<p>[X] Rule 13d-1(c)<\/p>\n<p>[ ] Rule 13d-1(d)<\/p>\n<\/p>\n<p>*The remainder of this cover page shall be filled out for a reporting<br \/>\nperson&#8217;s<\/p>\n<p>initial filing on this form with respect to the subject class of securities,<br \/>\nand<\/p>\n<p>for any subsequent amendment containing information which would alter the\n<\/p>\n<p>disclosures provided in a prior cover page.<\/p>\n<p>The information required in the remainder of this cover page shall not be<br \/>\ndeemed<\/p>\n<p>to be &#8220;filed&#8221; for the purpose of Section 18 of the Securities Exchange Act of\n<\/p>\n<p>1934 (&#8220;Act&#8221;) or otherwise subject to the liabilities of that section of the<br \/>\nAct<\/p>\n<p>but shall be subject to all other provisions of the Act (however, see the\n<\/p>\n<p>Notes).<\/p>\n<\/p>\n<p>&lt;<\/p>\n<p>PAGE&gt;<\/p>\n<\/p>\n<p>CUSIP No. 032092-30-6<\/p>\n<p>\n&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;\n<\/p>\n<p>(1) Names of Reporting Persons. I.R.S. Identification Nos. of Above Persons\n<\/p>\n<p>(entities only):<\/p>\n<p>Jonathan Gallen<\/p>\n<p>\n&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;\n<\/p>\n<p>(2) Check the Appropriate Box if a Member of a Group (See Instructions)<\/p>\n<p>(a) (b)<\/p>\n<p>\n&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;\n<\/p>\n<p>(3) SEC Use Only<\/p>\n<p>\n&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;\n<\/p>\n<p>(4) Citizenship or Place of Organization: United States<\/p>\n<p>\n&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;\n<\/p>\n<p>Number of Shares Beneficially Owned<\/p>\n<p>by Each Reporting Person With (5) Sole Voting Power: 250,000*<\/p>\n<p>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<\/p>\n<p>(6) Shared Voting Power: 0<\/p>\n<p>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<\/p>\n<p>(7) Sole Dispositive Power: 250,000*<\/p>\n<p>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<\/p>\n<p>(8) Shared Dispositive Power: 0<\/p>\n<p>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<\/p>\n<p>\n&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;\n<\/p>\n<p>(9) Aggregate Amount Beneficially Owned by Each Reporting Person: 250,000*\n<\/p>\n<p>\n&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;\n<\/p>\n<p>(10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See\n<\/p>\n<p>Instructions): N\/A<\/p>\n<p>\n&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;\n<\/p>\n<p>(11) Percent of Class Represented by Amount in Row (9): 6.4%*<\/p>\n<p>\n&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;\n<\/p>\n<p>(12) Type of Reporting Person (See Instructions): IA, IN<\/p>\n<p>\n&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;\n<\/p>\n<p>* As of April 1, 2008, Ahab Partners, L.P. (&#8220;Partners&#8221;) and Ahab<br \/>\nInternational,<\/p>\n<p>Ltd. (&#8220;International&#8221;) held in the aggregate 250,000 shares of Class A common\n<\/p>\n<p>stock, $0.01 par value per share (the &#8220;Shares&#8221;), of Ampex Corporation (the\n<\/p>\n<p>&#8220;Company&#8221;). Jonathan Gallen possesses sole power to vote and direct the<\/p>\n<p>disposition of all securities of the Company held by Partners and<br \/>\nInternational.<\/p>\n<p>Accordingly, for the purposes of Rule 13d-3 under the Securities Exchange Act<br \/>\nof<\/p>\n<p>1934, as amended, Mr. Gallen is deemed to beneficially own 250,000 Shares, or\n<\/p>\n<p>6.4% of the Shares deemed issued and outstanding as of April 1, 2008.<\/p>\n<\/p>\n<p>&lt;<\/p>\n<p>PAGE&gt;<\/p>\n<\/p>\n<p>Item 1(a). Name Of Issuer: Ampex Corporation<\/p>\n<p>Item 1(b). Address of Issuer&#8217;s Principal Executive Offices:<\/p>\n<p>1228 Douglas Avenue, Redwood City, California 94063-3117<\/p>\n<\/p>\n<p>Item 2(a). Name of Person Filing: Jonathan Gallen*<\/p>\n<p>Item 2(b). Address of Principal Business Office or, if None, Residence:<\/p>\n<p>299 Park Avenue, 17th Floor, New York, New York 10171<\/p>\n<p>Item 2(c). Citizenship: United States<\/p>\n<p>Item 2(d). Title of Class of Securities: Class A Common Stock, $0.01 par<br \/>\nvalue<\/p>\n<p>per share<\/p>\n<p>Item 2(e). CUSIP No.: 032092-30-6<\/p>\n<\/p>\n<p>Item 3. If This Statement Is Filed Pursuant to Sections 240.13d-1(b) or<\/p>\n<p>240.13d-2(b) or (c), check whether the Person Filing is a:<\/p>\n<p>Not applicable.<\/p>\n<\/p>\n<p>Item 4. Ownership<\/p>\n<p>(a) Amount Beneficially Owned (as of April 1, 2008): 250,000*<\/p>\n<p>(b) Percent of Class (as of April 1, 2008): 6.4%*<\/p>\n<p>(c) Number of Shares as to which the person has:<\/p>\n<p>(i) sole power to vote or to direct the vote 250,000*<\/p>\n<p>(ii) shared power to vote or to direct the vote 0<\/p>\n<p>(iii) sole power to dispose or to direct the<\/p>\n<p>disposition of 250,000*<\/p>\n<p>(iv) shared power to dispose or to direct the<\/p>\n<p>disposition of 0<\/p>\n<\/p>\n<p>__________________________<\/p>\n<p>* As of April 1, 2008, Ahab Partners, L.P. (&#8220;Partners&#8221;) and Ahab<br \/>\nInternational,<\/p>\n<p>Ltd. (&#8220;International&#8221;) held in the aggregate 250,000 shares of Class A common\n<\/p>\n<p>stock, $0.01 par value per share (the &#8220;Shares&#8221;), of Ampex Corporation (the\n<\/p>\n<p>&#8220;Company&#8221;). Jonathan Gallen possesses sole power to vote and direct the<\/p>\n<p>disposition of all securities of the Company held by Partners and<br \/>\nInternational.<\/p>\n<p>Accordingly, for the purposes of Rule 13d-3 under the Securities Exchange Act<br \/>\nof<\/p>\n<p>1934, as amended, Mr. Gallen is deemed to beneficially own 250,000 Shares, or\n<\/p>\n<p>6.4% of the Shares deemed issued and outstanding as of April 1, 2008.<\/p>\n<\/p>\n<p>&lt;<\/p>\n<p>PAGE&gt;<\/p>\n<\/p>\n<p>Item 5. Ownership of Five Percent or Less of a Class<\/p>\n<p>Not Applicable.<\/p>\n<\/p>\n<p>Item 6. Ownership of More Than Five Percent on Behalf of Another Person<\/p>\n<p>Not Applicable.<\/p>\n<\/p>\n<p>Item 7. Identification and Classification of the Subsidiary Which Acquired\n<\/p>\n<p>the Security Being Reported on by the Parent Holding Company or Control<\/p>\n<p>Person<\/p>\n<p>Not Applicable.<\/p>\n<\/p>\n<p>Item 8. Identification and Classification of Members of the Group<\/p>\n<p>Not Applicable.<\/p>\n<\/p>\n<p>Item 9. Notice of Dissolution of Group<\/p>\n<p>Not Applicable.<\/p>\n<\/p>\n<p>Item 10. Certification<\/p>\n<p>By signing below I certify that, to the best of my knowledge and<\/p>\n<p>belief, the securities referred to above were not acquired and are not held<br \/>\nfor<\/p>\n<p>the purpose of or with the effect of changing or influencing the control of<br \/>\nthe<\/p>\n<p>issuer of the securities and were not acquired and are not held in connection\n<\/p>\n<p>with or as a participant in any transaction having that purpose or effect.\n<\/p>\n<\/p>\n<\/p>\n<p>&lt;<\/p>\n<p>PAGE&gt;<\/p>\n<\/p>\n<p>SIGNATURE<\/p>\n<\/p>\n<p>After reasonable inquiry and to the best of my knowledge and belief, I<\/p>\n<p>certify that the information set forth in this statement is true, complete<br \/>\nand<\/p>\n<p>correct.<\/p>\n<\/p>\n<p>April 10, 2008<\/p>\n<\/p>\n<p>\/s\/ Jonathan Gallen<\/p>\n<p>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p>Jonathan Gallen, in his capacity as the<\/p>\n<p>investment manager for Ahab Partners,<\/p>\n<p>L.P., Ahab International, Ltd., Queequeg<\/p>\n<p>Partners, L.P., Queequeg, Ltd. and the<\/p>\n<p>Accounts<\/p>\n<\/p>\n<p>Attention: Intentional misstatements or omissions of fact constitute<\/p>\n<p>Federal criminal violations (See 18 U.S.C. 1001)<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"_stopmodifiedupdate":true,"_modified_date":"","_cloudinary_featured_overwrite":false},"corporate_contracts_companies":[6692],"corporate_contracts_industries":[9516],"corporate_contracts_types":[9629,9633],"class_list":["post-43911","corporate_contracts","type-corporate_contracts","status-publish","hentry","corporate_contracts_companies-ampex-corp","corporate_contracts_industries-telecommunications__equipment","corporate_contracts_types-securities","corporate_contracts_types-securities__shareholder"],"acf":[],"_links":{"self":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts\/43911","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts"}],"about":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/types\/corporate_contracts"}],"wp:attachment":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/media?parent=43911"}],"wp:term":[{"taxonomy":"corporate_contracts_companies","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_companies?post=43911"},{"taxonomy":"corporate_contracts_industries","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_industries?post=43911"},{"taxonomy":"corporate_contracts_types","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_types?post=43911"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}